Company Profile

MESOBLASTSADR (: MESO)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 46.47
% Price Change (last 13 weeks): 25.07
% Price Change (last 26 weeks): 62.83
% Price Change (last 52 weeks): 314.94
% Price Change (year to date): 324.09
Management Effectiveness
Return on Equity (%): -17.91
Return on Assets (%): -13.14
Return on Invested Capital (%): -14.52
Profitability
Gross Profit Margin (%): -166.30
Net Profit Margin (%): -1490.27
Operating Profit Margin (%): -996.80
Price & Volume
50-day Moving Average: $6.96
200-day Moving Average: $5.40
Avg. Daily Vol. (last 50 days): 153,582
Avg. Daily Vol. (last 200 days): 831,163
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
MESOBLASTSADR
55 Collins Street Level 38
Melbourne VI 3000

Phone: 61.3.9639.6036
Fax: 61.3.9639.6030
http://www.mesoblast.com
Per Share Data
Earnings (1year) ($): -0.89
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 4.21
Cash Flow ($): -0.73
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 113.85
Price/Book (x): 1.62
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.18
Current Ratio (x): 1.18
LT Debt/Equity (x): 21.32
Total Debt/Equity (x): 24.76



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.